Citigroup’s Inhibikase Therapeutics IKT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $39.8K | Sell |
20,393
-5,372
| -21% | -$10.5K | ﹤0.01% | 4151 |
|
|
2025
Q1 | $56.4K | Sell |
25,765
-51,335
| -67% | -$112K | ﹤0.01% | 4078 |
|
|
2024
Q4 | $251K | Buy |
+77,100
| New | +$251K | ﹤0.01% | 3450 |
|
|
2022
Q3 | – | Sell |
-83
| Closed | – | – | 5174 |
|
|
2022
Q2 | $0 | Buy |
+83
| New | – | ﹤0.01% | 5538 |
|